A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy

Radiotherapy and Oncology

Volumn 69, Issue 2, 2003, Pages 201-207

  Roeske, John C ^a   Bonta, Dacian ^a   Mell, Loren K ^a   Lujan, Anthony E ^a   Mundt, Arno J ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Department of Radiation Oncology ^*  (United States)

Author keywords

Complications; Gynecology; Intensity modulated radiation therapy; Modeling

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSIMETRY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MULTIVARIATE ANALYSIS; PELVIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RECTUM; SACRUM; SMALL INTESTINE; STATISTICAL SIGNIFICANCE; TARGET ORGAN; TUMOR VOLUME; UTERUS; VAGINA;

EID: 0345303982     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.05.001     Document Type: Article

References (28)

1. Ahamad A., D'Souza W., Salehpour M., et al. Intensity modulated radiation therapy (IMRT) for post-hysterectomy pelvic radiation: selection of patients and planning target volume (PTV). Int J Radiat Oncol Biol Phys. 54:(suppl 2):2002;42-43. abstract.
2. Baglan K.L., Frazier R.C., Yan D., et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 52:2002;176-183.
3. Buchali A., Koswig S., Dinges S., et al. Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynecological cancer. Radiother Oncol. 52:1999;29-34.
4. Chen Q., Izadifar N., King S., et al. Comparison of IMRT with 3-D CRT for gynecologic malignancies. Int J Radiat Oncol Biol Phys. 51:(Suppl. 3):2001;332. abstract.
5. Corn B.W., Lanciano R.M., Greven K.M., et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol. 12:1994;510-515.
6. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 355:2000;1404-1411.
7. Efron B., Tibshirani J. An introduction to the bootstrap. 1993;Chapman & Hall, New York. p. 45-8.
8. Gallagher M.J., Brereton H.D., Rostock R.A., et al. A prostpective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys. 12:1986;1565-1573.
9. Ghosh K., Padilla L.A., Murray K.P., et al. Using a belly board device to reduce the small bowel volume within pelvic radiation fields in women with postoperatively treated cervical cancer. Gynecol Oncol. 83:2001;271-275.
10. Grigsby P.W., Perez C.A. Radiotherapy alone for medically inoperable carcinoma of the cervix: stage IA and carcinoma in situ. Int J Radiat Oncol Biol Phys. 21:1991;375-378.
11. International Commission on Radiation Units and Measurements Report Number 50: prescribing, recording and reporting photon beam therapy. ICRU: Washington, DC; 1993.
12. Kavanagh B.D., Schefter T.E., Wu Q.W., et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Sem Radiat Oncol. 12:2002;260-271.
13. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 340:1999;1154-1161.
14. Koebl O., Richter S., Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys. 45:1999;1193-1198.
15. Mittelhammer R.C. The method of maximum likelihood in Mathematical statistics for economics and business. 1996;Springer, New York. p. 464-89.
16. Mundt A.J., Waggoner S.E., Rotmensch J., et al. Preoperative intracavitary brachytherapy in early stage cervical carcinoma. Am J Clin Oncol. 22:1999;737-741.
17. Mundt A.J., Roeske J.C., Lujan A.E., et al. Initial clinical experience using intensity-modulated whole pelvic radiation therapy for gynecologic malignancies. Gynecol Oncol. 82:2001;456-463.
18. Mundt A.J., Lujan A.E., Rotmensch J., et al. Intensity-modulated whole pelvic radiation therapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 52:2002;1330-1337.
19. Mundt A.J., Roeske J.C., Lujan A.E. Intensity modulated radiation therapy in gynecologic malignancies. Med Dosim. 27:2002;131-136.
20. Nuyttens J.J., Robertson J.M., Yan D., et al. The position and volume of small bowel during adjuvant radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 51:2001;1271-1280.
21. Perez C.A., Breaux S., Bedwinek J.M., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer. 54:1984;235-246.
22. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 51:2001;261-266.
23. Roeske J.C., Mundt A.J., Halpern H., et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. Int J Radiat Oncol Biol Phys. 37:1997;351-358.
24. Roeske J.C., Lujan A., Rotmensch J., et al. Intensity modulated whole pelvic radiation therapy in patients with gynecological malignancies. Int J Radiat Oncol Biol Phys. 48:2000;1613-1621.
25. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153.
26. Sailer S.L., Chaney E.L., Rosenman J.G., et al. Treatment planning at the University of North Carolina at Chapel Hill. Semin Radiat Oncol. 2:1992;267-273.
27. Sedlis A., Bundy B.N., Rotman M.Z., et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol. 73:1999;177-183.
28. Selvaraj R.N., Gerszten K., King G.C., et al. Conventional 3-D versus intensity modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative study of dose-volume histograms and the potential impact on toxicities. Int J Radiat Oncol Biol Phys. 51:(Suppl. 3):2001;218-219. abstract.